Cyclodextrin-Polyurethane Hydrogel for Drug Delivery
Tech ID
P27-1138
Patent Status
Granted in India
Design Status
--
Technical Description
The invention presents a novel drug delivery system using a biocompatible Cyclodextrin-grafted polyurethane hydrogel.
Problems Addressed
- Chemo side effects
- High normal cell toxicity
- High drug doses needed
- Skin cancer challenge
- Drug resistance issues
- Low drug bioavailability
- Adverse effects on tissues
- Poor melanoma treatment responses
- Less target-specific action
- Challenges in topical drug delivery
- Limited efficacy
TARGET AUDIENCE
- Pharmaceutical Industry
- Cancer Research
- Dermatology Clinics
- Biomedical Research Institutions
- Biotechnology Industry
- Chemical and Polymer Industries
TECH FEATURES
- Bioavailability Enhancement
- Targeted Delivery
- Eco-friendly Hydrogel
- Bio-compatible Hydrogel
- Targeted Drug Release
- Polymer Conjugates
- Cyclodextrin Grafting
- Drug-loaded Hydrogel
P27-1138
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com